Article
Oxidized LDL Is Associated with eGFR Decline in Proteinuric Diabetic Kidney Disease: A…
Oxidative Medicine and Cellular Longevity · 2021 · Stefanos Roumeliotis, author Athanasios Roumeliotis, author Panagiotis I. Georgianos, author Aikaterini Stamou, author Vangelis G. Manolopoulos, author Stylianos Panagoutsos, author Vassilios Liakopoulos, author Arantxa González, Academic Editor
Key facts
| Title | Oxidized LDL Is Associated with eGFR Decline in Proteinuric Diabetic Kidney Disease: A Cohort Study |
|---|---|
| First author | Stefanos Roumeliotis, author Athanasios Roumeliotis, author Panagiotis I. Georgianos, author Aikaterini Stamou, author Vangelis G. Manolopoulos, author Stylianos Panagoutsos, author Vassilios Liakopoulos, author Arantxa González, Academic Editor |
| Journal | Oxidative Medicine and Cellular Longevity |
| Published | Apr 15, 2021 |
| DOI | 10.1155/2021/2968869 |
| Devices mentioned | K843077, K843710, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185 and 3 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, DGC, KLB and 3 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1